john paulson
StreetInsider.com News Articles Thu, 12/15/2011 - 13:32
BioSante (Nasdaq: BPAX) 76.9% LOWER; says Libegel did not meet primary, secondary endpoints. Click here for the full report.
The stock was downgraded at JMP, Jefferies, Leerink Swann, Rodman & Renshaw and Roth Capital. SuperMedia (Nasdaq: SPMD) 32.5% HIGHER; shares breaking above resistance around $2.50 and $3.
NYT > Business Thu, 03/31/2011 - 20:20
John Paulson earned a record $4.9 billion in 2010 after a wager on gold. Other managers reaped big paychecks as their funds earned single-digit returns. 
StreetInsider.com News Articles Tue, 08/31/2010 - 15:52
Sunrise Senior Living Inc. (NYSE: SRZ) 15% HIGHER; announces revamped relationship with HCP to terminate contracts on 27 of the 75 senior housing communities.
HCP will pay Sunrise $50 million. Also litigation proceeding were dismissed. FormFactor Inc. (Nasdaq: FORM) 4% LOWER sees Q3 sales of $46-$48 million, versus the consensus of $57.3 million.
Netlist Inc. (Nasdaq: NLST) 3.6% LOWER; continues today's intra-day 8.7 percent sell-off into the close. NovaGold Resources Inc.
StreetInsider.com News Articles Wed, 11/18/2009 - 11:15
HIGHER;
- United States Oil Fund LP (NYSE: USO) is up about 0.82% to $40.81. Crude inventories dropped by about 887K, fueling Sweet Crude futures to rise $0.88 to $80.02.
- Financial Select Sector SPDR (NYSE: XLF) trading up modestly to $14.95, about a 0.61% gain.
The ETF is helped by a BofA Merrill Lynch report that investors don't see the Fed raising rates until H210.
Also, John Paulson said he thinks Bank of America (NYSE: BAC) will double in two years. BAC, which represents a 10.3% holding of the ETF, is up 3.1% today.
Claymore/Delta Global Shipping (NYSE:
StreetInsider.com News Articles Tue, 10/13/2009 - 15:38
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 16% LOWER; announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft, to autograft for use in hindfoot and ankle fusion surgery. Click here for the full report.
Conseco, Inc.
StreetInsider.com News Articles Tue, 10/13/2009 - 15:38
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 16% LOWER; announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft, to autograft for use in hindfoot and ankle fusion surgery. Click here for the full report.
Conseco, Inc.
StreetInsider.com News Articles Mon, 10/05/2009 - 09:26
StreetInsider.com's Best of the Web
StreetInsider.com News Articles Fri, 08/14/2009 - 08:27
Best of the Web - Sponsored By: GreenStocksCentral.com
Newsvine - business Wed, 08/12/2009 - 17:21
The hedge fund run by John Paulson, who foresaw the distress in subprime mortgages and reaped billions by betting against the related securities, has bought about 168 million shares of Bank of America Corp., according to a regulatory filing Wednesday.
|